13D/13G Filings - Monopar Therapeutics (MNPR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2025-02-07
5:01 pm
Purchase		2024-12-0913DMonopar Therapeutics Inc.
MNPR		Monopar Therapeutics
MNPR		704,829
13.400%		704,829increase
(New Position)		Filing
History
2025-01-08
11:38 am
Purchase		2024-12-3113GMonopar Therapeutics Inc.
MNPR		JANUS HENDERSON GROUP PLC
JHG		1,046,899
17.200%		484,417increase
(+86.12%)		Filing
History
2024-12-17
5:01 pm
Purchase		2024-12-0913DMonopar Therapeutics Inc.
MNPR		Tactic Pharma LLC1,037,396
19.200%		1,037,396increase
(New Position)		Filing
History
2024-11-06
3:13 pm
Purchase		2024-10-3113GMonopar Therapeutics Inc.
MNPR		JANUS HENDERSON GROUP PLC
JHG		562,482
10.900%		562,482increase
(New Position)		Filing
History
2024-10-31
4:17 pm
Purchase		2024-10-2413GMonopar Therapeutics Inc.
MNPR		RA CAPITAL MANAGEMENT L.P.511,207
9.700%		511,207increase
(New Position)		Filing
History
2024-10-28
06:00 am
Purchase		2024-10-2313GMonopar Therapeutics Inc.
MNPR		AstraZeneca PLC387,329
9.900%		387,329increase
(New Position)		Filing
History
2024-10-24
4:08 pm
Purchase		2024-10-2413GMonopar Therapeutics Inc.
MNPR		TANG CAPITAL MANAGEMENT LLC200,000
5.100%		200,000increase
(New Position)		Filing
History
2023-06-02
4:57 pm
Purchase		2023-05-2613GMonopar Therapeutics Inc.
MNPR		Klunzinger Jeffrey R.138,560
5.240%		138,560increase
(New Position)		Filing
History